Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0451641 (
urolithiasis
)
3,973
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A tubular renal damage induced by crystals in the renal tubuli can be the triggering primary but also secondary cause of stone formation. In 72 calcium oxalate stone patients (45 men, 27 women) N-acetyl-beta-D-glucosaminidase [
NAG
] excretion in 24h-urine was investigated. 48 healthy test persons (27 men, 21 women) served as a control group and helped to establish reference values. In order to find out a possible relation between
NAG
reference values and the risks of
urolithiasis
, lithogenous and inhibitory substances were determined in both groups. In the following, relative calcium oxalate supersaturation, representing a risk of urinary stone formation, was analyzed and compared to
NAG
excretion values. The threshold value of pathologic
NAG
excretion was determined in the group of healthy test subjects (mean value +/- 2 standard deviation) and was fixed at 4.2 U/d (women 3.06 U/d, men 4.24 U/d). In our investigations on
NAG
excretion significantly (p < 0.05) increased values were found in stone patients (4.43 U/d +/- 4.27) as compared to healthy test persons (2.13 U/d +/- 1.02). In the case of increased
NAG
excretion in stone patients there was a positive correlation between
NAG
excretion and increased phosphate, sulphate, uric acid, oxalate, and creatinine excretion. Only in female patients there was a relation between relative calcium oxalate supersaturation and
NAG
excretion values. As a result,
NAG
determination is considered to be an appropriate means of tracing a certain risk group within calcium oxalate stone patients.
...
PMID:N-acetyl-beta-D-glucosaminidase excretion in calcium oxalate stone patients and its relation to the risk of stone formation. 900 22
Idiopathic hypercalciuria (IH) is defined as hypercalciuria that persists after correction of dietary inbalances and has no detectable cause. The excretion of urinary N-acetyl-beta-D-glucosaminidase (U-NAG), a marker of proximal tubular damage, has been previously reported as either increased or normal in children with IH. We evaluated U-
NAG
in 20 children (13 boys and 7 girls, mean age 10.3 years +/- 5.7 SD) with IH (urinary calcium excretion above 0.1 mmol/kg/24 hours, with no detectable cause) and with otherwise normal renal function tests. Ultrasound examination revealed
urolithiasis
(n=4) and nephrocalcinosis (n=1). The U-
NAG
values were evaluated in the spot urine collected from the second morning void and calculated as the urinary
NAG
/creatinine ratio (U-NAG/Cr) and expressed in nkat/mmol. The 24-hour urinary calcium excretion (U-Ca/24h) was assessed in a urinary sample from 24-hour collected urine and calculated in mmol/kg. The obtained results of U-Ca/24h and U-
NAG
/Cr were expressed as Z-scores. When compared to the reference data, the U-Ca/24h and U-
NAG
/Cr were significantly higher (p = 0.0004 and p = 0.006, respectively). There was no correlation between the U-
NAG
/Cr and U-Ca/24h (r = 0.18, p = 0.20). The U-
NAG
/Cr values were significantly higher in the 5 patients with
urolithiasis
/nephrocalcinosis, whether compared to the rest of the group (p = 0.02), or to the reference data (p = 0.01). The U-
NAG
/Cr activity was higher in 15 children without
urolithiasis
/nephrocalcinosis when compared to reference data (p < 0.01). There was no difference in U-Ca/24h between the children with and without
urolithiasis
/nephrocalcinosis (p = 0.58). These findings suggest that tubular impairment, as reflected by U-
NAG
/Cr, might occur in children with IH, especially in patients with
urolithiasis
/nephrocalcinosis. There doesn't seem to be a direct relationship between the U-
NAG
/Cr activity and the degree of calcium leakage.
...
PMID:Renal tubular impairment in children with idiopathic hypercalciuria. 1695 19